Product Detail

Pharmacology of Infectious Disease
Digital Seminar
$99.99 USD
Product Details
Format:
Digital Seminar
Details:
Downloadable/Streaming MP4 Video and MP3 Audio with electronic manual and instructions.
Author:
ERIC WOMBWELL, PHARMD, BCIDP
Publisher:
PESI HealthCare
Copyright:
1/25/2021
CE Available:
No, CE credit is not available
Product Code:
POS078180
Objectives
  1. Develop antibiotic recommendations in response to microbiologic testing results.
  2. Describe clinical scenarios compelling for empiric coverage of resistant bacteria.
  3. Discriminate clinical scenarios requiring initiation of antibiotics.
  4. Choose appropriate risk factor–based empiric antibiotic regimens for acute infections.
  5. Recognize clinical scenarios necessitating avoidance of specific antibiotics based on side effect profiles.
  6. Identify clinical situations appropriate for newly approved antimicrobials.
Outline

Considerations for Successful Empiric Therapy

  • Spectrum of activity for commonly used antibiotics
  • Normal flora for infectious sites
  • Resistance associated with common bacteria
  • Pharmacodynamic influences on antibiotic dosing

Interpretation of Microbiologic Test Results 

  • Gram stain results
  • Culture and sensitivity results
  • Minimum inhibitory concentration (MIC) evaluation
  • PCR results

Antibacterial Resistance

  • Trends
  • Mechanisms of resistance
  • Contributing factors
  • Antibiotic stewardship concepts

Antibiotic Related Allergies– Penicillin and ‘Sulfa’

  • Define true allergy versus side effect
  • Penicillin allergy and cephalosporin cross sensitivity 
  • ‘Sulfa’ allergy

SARS-CoV-2

  • Clinical trial data for therapeutics
  • Clinical trial data for vaccines

Skin and Soft Tissue Infections

  • Streptococcus pyogenes vs. MRSA
  • Evidence for antibiotic management
  • IDSA treatment guidelines
  • Vancomycin AUC/MIC monitoring

Pneumonia

  • Evidence for pathogen etiology
  • Evidence for antibiotic management
  • IDSA/ATS community-acquired pneumonia treatment guidelines
  • Resistance risk factors and management
  • IDSA/ATS hospital- and ventilator-acquired pneumonia treatment guidelines
  • New antibiotics for MDR infections

Influenza

  • Evidence on vaccine timing and use in older adults
  • Clinical trial data for therapeutics
  • IDSA/CDC treatment guidelines

Urinary Tract Infections

  • Resistance trends
  • Clinical trial data for therapeutics
  • Antibiotics for MDR infections

Clostridium Difficile Infection

  • Risk factor literature review
  • Compare antibiotic risk levels
  • IDSA treatment guidelines
  • Clinical trial data for therapeutics
  • Probiotics prophylaxis evidence review
     
Author

ERIC WOMBWELL, PHARMD, BCIDP

Eric Wombwell is a board certified infectious diseases pharmacist and Clinical Associate Professor for the Department of Pharmacy Practice and Administration at the University of Missouri - Kansas City, School of Pharmacy. Wombwell is responsible for developing clinical and educational initiatives designed to optimize student learning. He is active in lecturing, research and hospital pharmacy practice.

Dr. Wombwell completed his PharmD degree at the University of Missouri Kansas City, followed by an ASHP accredited pharmacy practice residency at the Kansas City VA Medical Center. Upon residency completion, Wombwell accepted a full-time non-tenured clinical faculty position at the University of Missouri - Kansas City, School of Pharmacy. His responsibilities include teaching Doctor of Pharmacy students in a variety of courses, with special emphasis in the area of infectious diseases. As part of this position, Wombwell serves as a Clinical Pharmacy Specialist, working as part of the multidisciplinary team, providing care to acutely ill patients at Centerpoint Medical Center in Independence, Missouri. In addition, Wombwell functions in an adjunct faculty capacity with the University of Missouri - Kansas City, School of Dentistry, where he is responsible for teaching infectious diseases curricular content to dental students in the Pharmacology and Therapeutics course series.

Dr. Wombwell has more than 20 peer-reviewed publications on pharmacy and medication-related topics, and has delivered more than 50 invited presentations locally and nationally for continuing education to various health-professional audiences. He has been named Teacher-of-the-Year in various capacities 7 times, "Missouri Pharmacist Association - UMKC Faculty Member of the Year" in 2016, and received the "UMKC Provost's Award for Excellence in Teaching" in 2014.

Speaker Disclosures:

Financial: Eric Wombwell is a Clinical Assistant Professor, Department of Pharmacy Practice at the University of Missouri – Kansas City. He receives a speaking honorarium from PESI, Inc.

Non-financial: Eric Wombwell has no relevant nonfinancial relationships to disclose.
Continuing Education Credits
CE Credit is not available for this product.
Audience

Inpatient and outpatient pharmacists engaged in review of antimicrobial prescription orders. In particular, those pharmacists interested in obtaining further antimicrobial expertise to aid in the care of patients with infectious diseases through optimal antimicrobial drug choice, route, dose, and duration of use.